切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2026, Vol. 20 ›› Issue (01) : 1 -3. doi: 10.3877/cma.j.issn.1674-1358.2026.01.001

述评

感染性疾病创新药物研发:现状、挑战与未来图景
金荣华()   
  1. 100015 北京,首都医科大学附属北京地坛医院
  • 收稿日期:2026-01-06 出版日期:2026-02-15
  • 通信作者: 金荣华
  • Received:2026-01-06 Published:2026-02-15
引用本文:

金荣华. 感染性疾病创新药物研发:现状、挑战与未来图景[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(01): 1-3.

图1 感染性疾病创新药研发报告封面
[1]
GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023[J]. Lancet,2025,406(10513):1811-1872.
[2]
GBD 2023 Causes of Death Collaborators. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023[J]. Lancet,2025,406(10513):1731-1810.
[3]
GBD 2023 Causes of Death Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050[J]. Lancet,2024,404(10459):1199-1226.
[4]
Zhang C, Fu X, Liu Y, et al. Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019[J]. Lancet Reg Health West Pac,2024,43:100972.
[5]
Zhao ZY, Li JJ, Ouyang HQ, et al. Enhancing regional disease burden estimates: insights from the comparison of Global Burden of Disease and China’s notifiable infectious diseases data with policy implications (2010-2020)[J]. Infect Dis Poverty,2025,14(1):81.
[6]
Olliaro P, Torreele E. Global challenges in preparedness and response to epidemic infectious diseases[J]. Mol Ther,2022,30(5):1801-1809.
[7]
Bergkessel M, Forte B, Gilbert IH. Small-molecule antibiotic drug development: Need and challenges[J]. ACS Infect Dis,2023,9(11):2062-2071.
[8]
Bamford A, Masini T, Williams P, et al. Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics[J]. Lancet Child Adolesc Health,2024,8(6):456-466.
[9]
Nachega JB, Scarsi KK, Gandhi M, et al. Long-acting antiretrovirals and HIV treatment adherence[J]. Lancet HIV,2023,10(5):e332-e342.
[10]
Naggie S, Lok AS. New Therapeutics for hepatitis B: The road to cure[J]. Annu Rev Med,2021,72:93-105.
No related articles found!
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?